InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by Sharp John P, Chief Financial Officer. Director active across 2 companies, notably PhaseBio Pharmaceuticals Inc. In total, 11 reports have been logged. History available since 20 May 2021. The latest transaction was filed on 20 May 2022 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations11 total
6,026 shares@ US$0.68134.7% of flowCommon StockSEC:0001169245-22-000074:0
2,017 shares@ US$2.014.4% of flowCommon StockSEC:0001169245-21-000127:0
2,017 shares@ US$2.014.4% of flowCommon StockSEC:0001169245-21-000127
7,500 shares@ US$1.6813.3% of flowCommon StockSEC:0001169245-21-000103:0
7,500 shares@ US$1.6813.3% of flowCommon StockSEC:0001169245-21-000103
7,500 shares@ US$1.6813.0% of flowCommon StockSEC:0001169245-21-000087:0
7,500 shares@ US$1.6813.0% of flowCommon StockSEC:0001169245-21-000087
7,500 shares@ US$1.6813.0% of flowCommon StockSEC:0001169245-21-000071:0
7,500 shares@ US$1.6813.0% of flowCommon StockSEC:0001169245-21-000071
1,419 shares@ US$2.804.0% of flowCommon StockSEC:0001169245-21-000047
1,419 shares@ US$2.804.0% of flowCommon StockSEC:0001169245-21-000047:0
11 of 11 declarations
About Sharp John P
John P. Sharp is the Chief Financial Officer at PhaseBio Pharmaceuticals Inc. He is responsible for the financial management of the company, including financial planning and analysis. His expertise is crucial in supporting the growth and sustainability of PhaseBio.
